Gostner JM, Becker K, Überall G, Fuchs D. The potential of targeting indoleamine 2,3-dioxygenase for cancer treatment. Expert Opin Ther Targets. 2015 Feb 15:1-11.
Gostner JM, Becker K, Ueberall F, Fuchs D. The good and bad of antioxidant foods: An immunological perspective. Food Chem Toxicol. 2015 Feb 16;80:72-
Gostner JM, Ganzera M, Becker K, Geisler S, Schroecksnadel S, Uberall F, Schennach H, Fuchs D. Lavender oil suppresses indoleamine 2,3-dioxygenase activity in human PBMC. BMC Complement Altern Med. 2014 Dec 16;14(1):503.
Gostner J, Ciardi C, Becker K, Fuchs D, Sucher R. Immunoregulatory impact of food antioxidants. Curr Pharm Des. 2014;20(6):840-9.
Gostner JM, Becker K, Fuchs D, Sucher R. Redox regulation of the immune response. Redox Rep. 2013 Apr 19. 2013;18(3):88-94.
Becker K, Schroecknsadel S, Geisler S, Carriere M, Gostner JM, Schennach H, Herlin N, Fuchs D. TiO2 nanoparticles and bulk material stimulate human peripheral blood mononuclear cells. Food Chem Toxicol. 2013 Dec 19. pii: S0278-6915(13)00840-5. doi: 10.1016/j.fct.2013.12.018.
Klein A, Wrulich OA, Jenny M, Gruber P, Becker K, Fuchs D, Gostner JM, Uberall F. Pathway-focused bioassays and transcriptome analysis contribute to a better activity monitoring of complex herbal remedies. BMC Genomics. 2013 Feb 27;14:133.
Geisler S, Gostner JM, Becker K, Ueberall F, Fuchs D. Immune activation and inflammation increase the plasma phenylalanine to tyrosine ratio. Pteridines 2013, DOI 10.1515/pterid-2013-0001.
Gostner JM, Schröcksnadel S, Becker K, Jenny M, Schennach H, Uberall F, Fuchs D. Antimalarial drug chloroquine counteracts activation of indoleamine (2,3)-dioxygenase activity in human PBMC. FEBS Open Bio. 2012 Aug 17;2:241-5.
Gostner JM, Fong D, Wrulich OA, Lehne F, Zitt M, Hermann M, Krobitsch S, Martowicz A, Gastl G, Spizzo G. Effects of EpCAM overexpression on human breast cancer cell lines. BMC Cancer. 2011 Jan 31;11:45.
